Daily pill can double survival time for world’s deadliest cancer, trial shows
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest (…)
Site référencé: The Guardian (Asia Pacific)
3944.jpg?width=140&quality=85&auto=format&fit=max&s=3b43846a257ff075508ffce8a1f47d39, 3944.jpg?width=460&quality=85&auto=format&fit=max&s=7cc9fbebcd71e89831ebf650f0cbb809, 3944.jpg?width=700&quality=85&auto=format&fit=max&s=3205c77dea48b719949e7d6320e5d2ce
The Guardian (Asia Pacific)
Google owner Alphabet to sell $80bn in stock to fund AI spending spree
2/06/2026
UK students and graduates : share your views on going to university
2/06/2026
A red box for Donald Trump, and eight weeks to make it. Now I really am outraged by the Mandy files | Marina Hyde
2/06/2026
Wanted : surefire recipes for barbecue marinades and sauces | Kitchen aide
2/06/2026
The Jilly Cooper blowdry is back ! Twelve other big 80s hairstyles to try now
2/06/2026
Crossword editor’s desk : celebrating 30,000 cryptics with a treasure hunt
2/06/2026